Log In
BCIQ
Print this Print this
 

S-033188

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionCap-dependent endonuclease inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationInfluenza virus
Indication DetailsTreat influenza virus infection
Regulatory Designation
PartnerRoche

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/29/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today